Inventor · disambiguated record
Jacob M. Waugh
Also filed as: WAUGH JACOB · WAUGH JACOB M
39 granted patents·46 pending applications·476 citations·filing 2001–2025
98Inventor score
Files withREVANCE THERAPEUTICS INC33WAUGH JACOB M11CANDESANT BIOMEDICAL INC8DAKE MICHAEL D8ILLUSTRIS PHARMACEUTICALS INC5
Top patents by PatentIndex Score
85 records- 0196US9211248B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsREVANCE THERAPEUTICS INC·Filed 2013·Granted Dec 15, 2015·21 cites·76 claims
- 0295US10201594B2Compositions and methods for safe treatment of rhinitisREVANCE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·14 cites·8 claims
- 0395US10111939B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·16 cites·38 claims
- 0495US8404249B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsDAKE MICHAEL D·Filed 2005·Granted Mar 26, 2013·36 cites·76 claims
- 0595US8092788B2Compositions and methods for topical diagnostic and therapeutic transportDAKE MICHAEL D·Filed 2005·Granted Jan 10, 2012·26 cites·56 claims
- 0694US10080786B2Methods for treating pain by topical application and transdermal delivery of botulinum toxinREVANCE THERAPEUTICS INC·Filed 2015·Granted Sep 25, 2018·12 cites·45 claims
- 0794US9180081B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsDAKE MICHAEL D·Filed 2006·Granted Nov 10, 2015·20 cites·41 claims
- 0894US8398997B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsDAKE MICHAEL D·Filed 2005·Granted Mar 19, 2013·28 cites·182 claims
- 0992US9340587B2Albumin-free botulinum toxin formulationsTHOMPSON STEWART A·Filed 2010·Granted May 17, 2016·22 cites·146 claims
- 1092US8518414B2Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteinsWAUGH JACOB M·Filed 2006·Granted Aug 27, 2013·20 cites·16 claims
- 1192US8022179B2Compositions and methods for topical application and transdermal delivery of an oligopeptideREVANCE THERAPEUTICS INC·Filed 2006·Granted Sep 20, 2011·17 cites·26 claims
- 1291US11033425B2Medical devices for generating heat and methods of treatment using sameCANDESANT BIOMEDICAL INC·Filed 2020·Granted Jun 15, 2021·3 cites·19 claims
- 1390US8974774B2Compositions and methods for topical diagnostic and therapeutic transportDAKE MICHAEL D·Filed 2005·Granted Mar 10, 2015·11 cites·10 claims
- 1490US8568740B2Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteinsWAUGH JACOB M·Filed 2006·Granted Oct 29, 2013·13 cites·10 claims
- 1589US11844668B2Medical devices for generating heat and methods of treatment using sameCANDESANT BIOMEDICAL INC·Filed 2022·Granted Dec 19, 2023·1 cites·30 claims
- 1689US10744078B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsREVANCE THERAPEUTICS INC·Filed 2018·Granted Aug 18, 2020·5 cites·20 claims
- 1789US9314416B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsDAKE MICHAEL D·Filed 2006·Granted Apr 19, 2016·9 cites·37 claims
- 1888US10172877B2Compositions and methods for topical diagnostic and therapeutic transportDAKE MICHAEL D·Filed 2015·Granted Jan 8, 2019·5 cites·17 claims
- 1988US7807780B2Multi-component biological transport systemsREVANCE THERAPEUTICS INC·Filed 2001·Granted Oct 5, 2010·28 cites·6 claims
- 2088US2024382571A1Albumin-Free Botulinum Toxin FormulationsREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2187US9956435B2Injectable botulinum toxin formulationsRUEGG CURTIS L·Filed 2009·Granted May 1, 2018·15 cites·49 claims
- 2285US11351232B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Granted Jun 7, 2022·1 cites·19 claims
- 2384US11433028B2Compositions for treating viral infections and methods for sameTIGER DEV LLC·Filed 2021·Granted Sep 6, 2022·1 cites·12 claims
- 2483US2024058628A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2582US12337065B2Compositions for treating viral infections and methods for sameACCESS TO ADVANCED HEALTH INST·Filed 2022·Granted Jun 24, 2025·0 cites·20 claims
- 2681US10575983B2Medical devices for generating heat and methods of treatment using sameCANDESANT BIOMEDICAL INC·Filed 2016·Granted Mar 3, 2020·4 cites·27 claims
- 2781US8623811B2Antimicrobial peptide, compositions, and methods of useSTONE HONGRAN F·Filed 2008·Granted Jan 7, 2014·10 cites·55 claims
- 2881US2025205080A1Medical devices for generating heat and methods of treatment using the sameCANDESANT BIOMEDICAL INC·Filed 2024·Application pending·0 cites
- 2980US8580317B2Compositions and methods for treating acneWAUGH JACOB M·Filed 2006·Granted Nov 12, 2013·4 cites·9 claims
- 3079US7056339B2Drug delivery platformUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jun 6, 2006·73 cites·48 claims
- 3178US12036148B2Medical devices for generating heat and methods of treatment using sameCANDESANT BIOMEDICAL INC·Filed 2022·Granted Jul 16, 2024·0 cites·28 claims
- 3277US11911449B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 3377US8815954B2Arginine heteromers for topical administrationWAUGH JACOB M·Filed 2006·Granted Aug 26, 2014·2 cites·12 claims
- 3476US12257293B2Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2021·Granted Mar 25, 2025·0 cites·9 claims
- 3575US7048939B2Methods for the inhibition of neointima formationUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted May 23, 2006·58 cites·30 claims
- 3674US2010166689A1Compositions and Methods for Treating HyperpigmentationREVANCE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3773US8628756B2Arginine heteromers for topical administrationWAUGH JACOB M·Filed 2006·Granted Jan 14, 2014·1 cites·39 claims
- 3873US2021069224A1Compositions and Methods for Topical and Diagnostic and Therapeutic TransportREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3973US2020101097A1Compositions and Methods for Topical and Diagnostic and Therapeutic TransportREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4072US2025319168A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4172US2012014894A1Compositions and Methods for Treating HyperpigmentationWAUGH JACOB M·Filed 2009·Application pending·0 cites
- 4271US12076271B2Medical devices for generating heat and methods of treatment using the sameCANDESANT BIOMEDICAL INC·Filed 2020·Granted Sep 3, 2024·0 cites·26 claims
- 4370US12083204B2Topical composition for homeostatic delivery of nitric oxide and uses thereofOREAL·Filed 2022·Granted Sep 10, 2024·0 cites·24 claims
- 4467US11471708B2Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·13 claims
- 4567US2021189326A1Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositionsREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4666US2022062400A1Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4766US2021059855A1Medical devices for generating heat and methods of treatment using sameCANDESANT BIOMEDICAL INC·Filed 2020·Application pending·0 cites
- 4865US12508252B2Compositions and methods for pain relief and numbingZIROPA INC·Filed 2021·Granted Dec 30, 2025·0 cites·15 claims
- 4964US2020345819A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5064US2014120077A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jacob M. Waugh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →